Cincinnati pharma firm makes $42M public offering, uplists stock

Aerpio Pharmaceuticals Inc. intends to sell nearly $42 million of its common stock in an underwritten public offering, and its shares that had been traded on the OTCQB market began trading on the Nasdaq market on Tuesday under the symbol “ARPO.”